Effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy: A protocol of systematic review and meta-analysis.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
05 Jun 2020
05 Jun 2020
Historique:
entrez:
6
6
2020
pubmed:
6
6
2020
medline:
1
7
2020
Statut:
ppublish
Résumé
This systematic review aims to assess the effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy. We will search Cochrane Library, PUBMED, EMBASE, CINAHL, Web of Science, Google Scholar, PsycINFO, WANGFANG, VIP, CBM, and CNKI from their inceptions to the March 31, 2020, without language restrictions. Two authors will independently carry out searching literature records, scanning titles and abstracts, full texts, collecting data, and assessing risk of bias. RevMan 5.3 software will be used for statistical analysis. This systematic review will investigate whether cinnamaldehyde is effective on Cav-1 and Survivin expression in epilepsy. Its findings will provide helpful evidence for the effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy.Systematic review registration: INPLASY202040152.
Sections du résumé
BACKGROUND
BACKGROUND
This systematic review aims to assess the effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy.
METHODS
METHODS
We will search Cochrane Library, PUBMED, EMBASE, CINAHL, Web of Science, Google Scholar, PsycINFO, WANGFANG, VIP, CBM, and CNKI from their inceptions to the March 31, 2020, without language restrictions. Two authors will independently carry out searching literature records, scanning titles and abstracts, full texts, collecting data, and assessing risk of bias. RevMan 5.3 software will be used for statistical analysis.
RESULTS
RESULTS
This systematic review will investigate whether cinnamaldehyde is effective on Cav-1 and Survivin expression in epilepsy.
CONCLUSION
CONCLUSIONS
Its findings will provide helpful evidence for the effect of cinnamaldehyde on Cav-1 and Survivin expression in epilepsy.Systematic review registration: INPLASY202040152.
Identifiants
pubmed: 32501993
doi: 10.1097/MD.0000000000020459
pii: 00005792-202006050-00031
pmc: PMC7306385
doi:
Substances chimiques
BIRC5 protein, human
0
CAV1 protein, human
0
Caveolin 1
0
Survivin
0
Acrolein
7864XYD3JJ
cinnamaldehyde
SR60A3XG0F
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20459Références
Ann Neurosci. 2018 Dec;25(4):177-186
pubmed: 31000955
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
J Glob Health. 2017 Dec;7(2):020706
pubmed: 29302325
Arch Med Sci. 2018 Jun;14(4):717-724
pubmed: 30002687
Epilepsy Res. 2013 Jul;105(1-2):195-205
pubmed: 23507331
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1289-1291
pubmed: 30846541
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Seizure. 2018 May;58:22-28
pubmed: 29609146
Epilepsia. 2005 Apr;46(4):470-2
pubmed: 15816939
Acta Neurol Scand. 2018 Dec;138(6):541-547
pubmed: 30125939
Syst Rev. 2018 Jul 18;7(1):95
pubmed: 30021618
Epilepsy Res. 2017 Jul;133:98-102
pubmed: 28475999
Neurology. 2017 Jan 17;88(3):296-303
pubmed: 27986877
Epilepsia. 2018 Jun;59(6):1198-1207
pubmed: 29600809
Front Neurol. 2019 Mar 01;10:166
pubmed: 30890997
Syst Rev. 2019 Mar 27;8(1):75
pubmed: 30917869
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Health Technol Assess. 2018 Apr;22(21):1-142
pubmed: 29717699
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Seizure. 2015 Jul;29:46-62
pubmed: 26076844
Neurology. 2019 Jun 11;92(24):e2815-e2821
pubmed: 31101739
Epilepsia. 2018 Jul;59(7):1344-1350
pubmed: 29889310